Publication | Closed Access
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
85
Citations
37
References
2020
Year
Dual G9a/DNMT1 inhibition by compounds like CM272 may be a novel therapeutic strategy for treating liver fibrosis.
| Year | Citations | |
|---|---|---|
2007 | 1.9K | |
2004 | 1K | |
2013 | 814 | |
2012 | 777 | |
2016 | 571 | |
2015 | 560 | |
2014 | 527 | |
2012 | 501 | |
2012 | 419 | |
2008 | 405 |
Page 1
Page 1